Animal and Clinical Studies Evaluating Blood Glucose Control With Palatinose-Based Alternative Sweeteners

Animal and clinical studies were performed to determine whether Palatinose-based alternative sweeteners with increased sweetness contributed to blood glucose elevations. In the animal study, male Sprague-Dawley rats (6 weeks old) received an oral load of 2 g of glucose or Palatinose-based alternativ...

Full description

Bibliographic Details
Main Authors: Jaehyi Jang, Kyungae Jo, Ki-Bae Hong, Eun Young Jung
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnut.2020.00052/full
_version_ 1818134105386123264
author Jaehyi Jang
Kyungae Jo
Ki-Bae Hong
Eun Young Jung
author_facet Jaehyi Jang
Kyungae Jo
Ki-Bae Hong
Eun Young Jung
author_sort Jaehyi Jang
collection DOAJ
description Animal and clinical studies were performed to determine whether Palatinose-based alternative sweeteners with increased sweetness contributed to blood glucose elevations. In the animal study, male Sprague-Dawley rats (6 weeks old) received an oral load of 2 g of glucose or Palatinose-based alternative sweeteners per kilogram of body weight. Thirty minutes after the glucose load, the rat blood glucose levels in the Palatinose-based alternative sweetener groups were significantly lower than those in the glucose groups (p < 0.05). Palatinose-based alternative sweeteners significantly improved glucose tolerance in rats. However, significant differences in the blood glucose levels were not observed among the Palatinose-based alternative sweeteners. In the clinical study, 14 healthy volunteers (21.4 ± 1.3 years) consumed glucose or Palatinose-based alternative sweeteners (50 g). At 60 min, when Palatinose-based alternative sweeteners were ingested, blood glucose was significantly lower compared to when glucose was ingested (Palatinose-L, 123.1 mg/dL; Palatinose-IS, 125.9 mg/dL; Palatinose-FOS. 129.1 mg/dL vs. glucose, 154.8 mg/dL, p < 0.05). The glycaemic index of Palatinose-L, Palatinose-IS and Palatinose-FOS was 43.9, 58.1, and 49.2, respectively. Palatinose-based alternative sweeteners could help maintain health as the postprandial blood glucose levels are constantly maintained owing to slow hydrolysis.
first_indexed 2024-12-11T09:03:20Z
format Article
id doaj.art-903d53cbae23405fae15494c5b893ee3
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-12-11T09:03:20Z
publishDate 2020-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-903d53cbae23405fae15494c5b893ee32022-12-22T01:13:42ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2020-04-01710.3389/fnut.2020.00052531823Animal and Clinical Studies Evaluating Blood Glucose Control With Palatinose-Based Alternative SweetenersJaehyi Jang0Kyungae Jo1Ki-Bae Hong2Eun Young Jung3Department of Integrated Biomedical and Life Sciences, Graduate School, Korea University, Seoul, South KoreaBK21 Plus, College of Health Science, Korea University, Seoul, South KoreaDepartment of Food and Nutrition, Dongduk Women's University, Seoul, South KoreaDepartment of Home Economic Education, Jeonju University, Jeonju, South KoreaAnimal and clinical studies were performed to determine whether Palatinose-based alternative sweeteners with increased sweetness contributed to blood glucose elevations. In the animal study, male Sprague-Dawley rats (6 weeks old) received an oral load of 2 g of glucose or Palatinose-based alternative sweeteners per kilogram of body weight. Thirty minutes after the glucose load, the rat blood glucose levels in the Palatinose-based alternative sweetener groups were significantly lower than those in the glucose groups (p < 0.05). Palatinose-based alternative sweeteners significantly improved glucose tolerance in rats. However, significant differences in the blood glucose levels were not observed among the Palatinose-based alternative sweeteners. In the clinical study, 14 healthy volunteers (21.4 ± 1.3 years) consumed glucose or Palatinose-based alternative sweeteners (50 g). At 60 min, when Palatinose-based alternative sweeteners were ingested, blood glucose was significantly lower compared to when glucose was ingested (Palatinose-L, 123.1 mg/dL; Palatinose-IS, 125.9 mg/dL; Palatinose-FOS. 129.1 mg/dL vs. glucose, 154.8 mg/dL, p < 0.05). The glycaemic index of Palatinose-L, Palatinose-IS and Palatinose-FOS was 43.9, 58.1, and 49.2, respectively. Palatinose-based alternative sweeteners could help maintain health as the postprandial blood glucose levels are constantly maintained owing to slow hydrolysis.https://www.frontiersin.org/article/10.3389/fnut.2020.00052/fullpalatinoseisomaltulosealternative sweetenerblood glucoseglycaemic index
spellingShingle Jaehyi Jang
Kyungae Jo
Ki-Bae Hong
Eun Young Jung
Animal and Clinical Studies Evaluating Blood Glucose Control With Palatinose-Based Alternative Sweeteners
Frontiers in Nutrition
palatinose
isomaltulose
alternative sweetener
blood glucose
glycaemic index
title Animal and Clinical Studies Evaluating Blood Glucose Control With Palatinose-Based Alternative Sweeteners
title_full Animal and Clinical Studies Evaluating Blood Glucose Control With Palatinose-Based Alternative Sweeteners
title_fullStr Animal and Clinical Studies Evaluating Blood Glucose Control With Palatinose-Based Alternative Sweeteners
title_full_unstemmed Animal and Clinical Studies Evaluating Blood Glucose Control With Palatinose-Based Alternative Sweeteners
title_short Animal and Clinical Studies Evaluating Blood Glucose Control With Palatinose-Based Alternative Sweeteners
title_sort animal and clinical studies evaluating blood glucose control with palatinose based alternative sweeteners
topic palatinose
isomaltulose
alternative sweetener
blood glucose
glycaemic index
url https://www.frontiersin.org/article/10.3389/fnut.2020.00052/full
work_keys_str_mv AT jaehyijang animalandclinicalstudiesevaluatingbloodglucosecontrolwithpalatinosebasedalternativesweeteners
AT kyungaejo animalandclinicalstudiesevaluatingbloodglucosecontrolwithpalatinosebasedalternativesweeteners
AT kibaehong animalandclinicalstudiesevaluatingbloodglucosecontrolwithpalatinosebasedalternativesweeteners
AT eunyoungjung animalandclinicalstudiesevaluatingbloodglucosecontrolwithpalatinosebasedalternativesweeteners